Rifampin as a novel trigger of drug-induced enterocolitis syndrome
IJTLD Open · 2026-07 · 3 (7) · 471-474
DOI: 10.5588/ijtldopen.26.0133 ↗Kurz gefasst
Fallbericht in der Zeitschrift IJTLD Open, online erschienen am 01.07.2026. Verfasst von A Tamborino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Infectious Diseases Unit, Meyer Children's Hospital IRCCS, Florence, Italy. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pediatric Infectious Diseases Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
- Allergy Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
- Department of Health Sciences, University of Florence, Florence, Italy.
- Pediatric Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Zitieren
APA
Tamborino, A., Liccioli, G., Tomei, L., Chiappini, E., Trapani, S., Mori, F., Galli, L., & Venturini, E. (2026). Rifampin as a novel trigger of drug-induced enterocolitis syndrome. IJTLD Open, 3(7), 471-474. https://doi.org/10.5588/ijtldopen.26.0133
Vancouver
Tamborino A, Liccioli G, Tomei L, Chiappini E, Trapani S, Mori F, et al. Rifampin as a novel trigger of drug-induced enterocolitis syndrome. IJTLD Open. 2026;3(7):471-474. doi:10.5588/ijtldopen.26.0133
BibTeX
@article{Tamborino2026,
author = {Tamborino, A and Liccioli, G and Tomei, L and Chiappini, E and Trapani, S and Mori, F and Galli, L and Venturini, E},
title = {Rifampin as a novel trigger of drug-induced enterocolitis syndrome},
journal = {IJTLD Open},
year = {2026},
volume = {3},
number = {7},
pages = {471--474},
doi = {10.5588/ijtldopen.26.0133}
}
EUVIMED